Description

Experience Mounjaro® (tirzepatide) delivered through a once-weekly injectable treatment designed to support metabolic health and medical weight management within a provider-directed program, helping regulate appetite and blood sugar response through a dual-hormone mechanism aligned with individualized care plans and ongoing medical evaluation when prescribed. Treatment Details Medicine Detail Information Medication Type Dual GIP and GLP-1 receptor agonist Form Subcutaneous injectable prescription medication Dosing Schedule Administered once weekly as provider directed Usage Category Metabolic health and medical weight management treatment option